Company Demonstrates Enhanced Performance In Management and Operations
Evonik Degussa Corporation’s Tippecanoe Laboratories has received the American Chemistry Council’s Responsible Care (RC) 14001 certification for enhanced performance in environmental, health, safety and security management systems.
The facility received the recognition after an extensive series of audits of its operations by UL DQSInc., an independent, third party firm that specializes in rigid technical and industry-specific assessments of companies. The auditors recommended the certification after examining the company’s performance in key areas such as community awareness and emergency response, security, safe product distribution, employee health and security, pollution prevention, process safety, and product stewardship.
“This is a very important milestone for management and employees at Tippecanoe Laboratories. It demonstrates diligent efforts to operate our facilities in a safe and environmentally protective manner,” said Gerwin Specka, Tippecanoe site manager.
RC 14001 is a revolutionary environmental, health, safety and security standard that integrates elements of the American Chemistry Council’s Responsible Care with the environmental management system guidelines established by the International Organization for Standardization.
Specka said it is incredibly gratifying and rewarding when an organization such as the UL DQS Inc. recognizes the commitment Evonik employees and management have to the community. Safety and environmental awareness is the foundation for Evonik’s operations and corporate culture, said Specka.
“As a leading global specialty chemical company, we have an obligation to society to conduct business in a responsible way,” said Mindy Stinson, Director of Human Resources at Tippecanoe Laboratories. “Our customers, employees and residents in the communities in which we live and work expect it. We will continually work to enhance these measures.”
Tippecanoe Laboratories manufactures a variety of specialty chemicals for ingredients in pharmaceutical medications that treat cancer, osteoporosis, lymphoma and fibromyalgia.
For additional information about Evonik in North America, please visit our website: www.evonik.com/north-america.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. In 2010 about 80 percent of the Group’s chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.